Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Mikami M et al. | Characteristic alteration in the concentration of IV 3NeuAc alpha-nLc4Cer in the villi of human placenta during the gestational period. | Placenta | pmid:8248034 | |
Sargeant TJ et al. | Characterization of inducible models of Tay-Sachs and related disease. | 2012 | PLoS Genet. | pmid:23028353 |
Seyrantepe V et al. | Mice doubly-deficient in lysosomal hexosaminidase A and neuraminidase 4 show epileptic crises and rapid neuronal loss. | 2010 | PLoS Genet. | pmid:20862357 |
Worstell NC et al. | Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array. | 2016 | PLoS ONE | pmid:27070150 |
Caughlin S et al. | Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of Aβ Toxicity and Stroke. | 2015 | PLoS ONE | pmid:26086081 |
Mahata B et al. | GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway. | 2015 | PLoS ONE | pmid:26226135 |
Sinici I et al. | In cellulo examination of a beta-alpha hybrid construct of beta-hexosaminidase A subunits, reported to interact with the GM2 activator protein and hydrolyze GM2 ganglioside. | 2013 | PLoS ONE | pmid:23483939 |
Wilkinson FL et al. | Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB. | 2012 | PLoS ONE | pmid:22558223 |
Kodama T et al. | Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease. | 2011 | PLoS ONE | pmid:22205997 |
Lemos M et al. | Prenatal diagnosis of GM2-gangliosidosis B1 variant. | 1995 | Prenat. Diagn. | pmid:7659693 |